Radiochemistry & Nuclear Imaging Lab Research groups

The activity of the Radiochemistry and Nuclear Imaging Group focuses on the development of innovative radiochemistry and the application of positron emission tomography (PET) and single photon emission computed tomography (SPECT) tracers toward the investigation of biological, physiological and pathological processes in the fields of oncology, neurology, pneumology, infection and cardiovascular diseases. The main research lines are described below.

Main Research Lines:

Fundamental radiochemistry

Development of innovative labeling strategies using 11C, 13N and 18F

Investigation of reaction mechanisms using labeled species

Nanotechnology and nanomedicine

Development of nanomaterial-based drugs with application in boron neutron capture therapy (BNCT)

Investigation of the biological fate of nanoparticles using in vivo imaging 

Evaluation of nanoparticles as drug carriers in infectious diseases

Development of nano-immunotherapeutic agents 

Translational applications

Longitudinal investigation of neurodegenerative diseases

Investigation of pathophysiological aspects of brain ischemia

Tumor metabolism 

Campo de investigación

Life & Medical Sciences

Prioridades RIS3
  • Biosciences & Health
Investigador principal
Jordi Llop
CIC biomaGUNE Parque tecnológico de Gipuzkoa Ed. Pº Miramón 182, 20014, San Sebastián
Cómo llegar
Principales líneas de investigación.
  • Fundamental radiochemistry
  • Nanotechnology and nanomedicine
  • Translational applications